BFI Infinity’s Biogen BIIB Stock Holding History

BFI Infinity’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.31M	Buy	+19,095	New	+$4.05M	2.03%	15

Other funds holding BIIB

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

BFI Infinity's BIIB Position: Q3 2026 in Review

BFI Infinity opened a new position in Biogen (BIIB) in Q3 2026: 19,095 shares worth $4.31M. The stake represents 2.03% of the portfolio and ranks #15 among its holdings.

126 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

BFI Infinity held 19,095 shares of Biogen worth $4.31M as of Q3 2026.
Biogen was a new BFI Infinity position in Q3 2026.
Biogen made up 2.03% of BFI Infinity's portfolio in Q3 2026, its #15 holding.
126 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on BFI Infinity's 13F filing for Q3 2026, filed 16 Oct 2026.